GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2 diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study population of lean and obese men and women with normal and impaired glucose regulation. Circulating concentrations of glucose, insulin, and GLP-1 during an oral glucose tolerance test (OGTT) were analyzed in individuals with normal glucose tolerance (NGT) (n = 774), prediabetes (n = 525), or screen-detected type 2 diabetes (n = 163) who attended the Danish ADDITION-PRO study (n = 1,462). Compared with individuals with NGT, women with prediabetes or type 2 diabetes had 25% lower GLP-1 response to an OGTT, and both men and women with prediabetes or type 2 diabetes had 16-21% lower 120-min GLP-1 concentrations independent of age and obesity. Obese and overweight individuals had up to 20% reduced GLP-1 response to oral glucose compared with normal weight individuals independent of glucose tolerance status. Higher GLP-1 responses were associated with better insulin sensitivity and β-cell function, older age, and lesser degree of obesity. Our findings indicate that a reduction in GLP-1 response to oral glucose occurs prior to the development of type 2 diabetes and obesity, which can have consequences for early prevention strategies for diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a limited body of evidence supporting a modest reduction in gut GLP-1 release in people living with obesity, which may be partly heritable (14, 132‐134).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [133]
In the citing paper
“There is a limited body of evidence supporting a modest reduction in gut GLP-1 release in people living with obesity, which may be partly heritable (14, 132‐134).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [133]
In the citing paper
“From a diabetes prevention perspective, the GLP-1-releasing effects of PUFAs could be particularly important, given that obese patients have lower GLP-1 responses to oral glucose than individuals of normal weight, irrespective of the glycemic status [52,53].”
From Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases (2020) · cites this paper as [52]
Citations
Cites
Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307 · cited 1×
“In type 2 diabetes, the incretin effect is impaired (2,3), but it remains controversial to what extent the defect is caused by a reduced release of incretin hormones and whether this reduction occurs prior to the development of type 2 diabetes.”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919
Gender differences in insulin resistance, body composition, and energy balance
Geer, E. B., & Shen, W. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.02.002 · Cited by 913
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 883 · cited 4×
“These findings are in agreement with the glucoregulatory effects of GLP-1 (33,34) and with studies showing that infusion of the GLP-1 receptor antagonist exendin-(9-39) reduced first-phase insulin release and decreased insulin action in healthy individuals and in patients with type 2 diabetes (35,36).”
BackgroundMethodResultInfluentialNAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874 · cited 1×
“The incretin hormones GLP-1 and glucose-dependent insulinotropic polypeptide contribute to glucose-stimulated insulin release and therefore play important roles in maintaining normal glucose regulation (1).”
BackgroundDeterminants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
Holst, J. J., & Gromada, J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00545.2003 · Cited by 611
Validation of the insulin sensitivity index (ISI0,120): comparison with other measures
Gutt, M., Davis, C. L., Spitzer, S. B., Llabre, M. M., Kumar, M., Czarnecki, E. M., Schneiderman, N., Skyler, J. S., & Marks, J. B. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00116-3 · Cited by 474
Cited by
Items 301–325 of 325
Prediabetes: Clinical Management and Nutrient Patterns Related to Diabetes Development
Newbold, E. A. (2020) · KU ScholarWorks (The University of Kansas) · Cited by 1
Type-2 Diabetes in Women/Metabolic Syndrome/ Insulin Resistance
Cigrovski Berković, M. (2024) · University of Zagreb University Computing Centre (SRCE)
Guo, J., Li, Z., Patel, S. A., CHANG, H. H., Ali, M. S., & Varghese, J. S. (2026) · Diabetes Care · doi:10.2337/dc25-2069
(2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33287-6.00006-5
Ghadzi, S. S., Karlsson, M. O., de Mello, V. D., Uusitupa, M., Kjellsson, M. C., & Finnish Diabetes Prevention Study Group (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.28.708712
“4 12 In this current study, however, the focus of the discussion will be on individuals with IGT, as the studied population.”
Neglected GLP-1 receptors in the eyes and nose: possible correlation with regulation of appetite
Saturnino, A., & Pozzilli, P. (2026) · Endocrine · doi:10.1007/s12020-026-04581-z · Cited by 1
Sun, Y., Xie, C., Bound, M. J., Jones, K. L., Horowitz, M., Macdonald, I. A., Young, R. L., Rayner, C. K., & Wu, T. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113235
Estafanos, S., West, D. W. D., Koussiouris, A., Moore, D. R., & Gillen, J. B. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00576.2025
Fourny, N. (2019) · theses.fr (ABES) · doi:10.70675/846aa6e5z8362z45a5z8e8dz2452913634b4
Α-gustducine intestinale : implication dans l'obésité et le diabète de type 2
Gléau, L. L. (2021) · theses.fr (ABES) · doi:10.70675/dc436e75zb6d2z4bb4zb9a1z17b025f205a6
Rahman, M. H., Kaligis, S. H. M., & Tiho, M. (2026) · Cerdika Jurnal Ilmiah Indonesia · doi:10.59141/cerdika.v6i4.3163
“Pada keadaan ini maka keunggulan fisiologis perempuan seolah dihilangkan (Færch et al., 2015).”
Covarrubias, M. J., Dib, T., Escobar-Luna, J., Moreno, R. D., Cáceres-Vergara, D., Saldías, C., Renard, G. M., Iturriaga‐Vásquez, P., Escobar, A. P., Torres, G. E., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1801283
“Moreover, circulating GLP-1 levels tend to be higher in women than in men (Adam and Westerterp-Plantenga, 2005; Faerch et al., 2015).”
Christensen, D. L., Emborg, C. O., Ramaiya, K. L., Maro, V. P., Bygbjerg, I. C., Sironga, J., Holst, J. J., Kilonzo, K., Hartmann, B., Dela, F., et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02710-8
Self-citationSerum Magnesium Levels and Their Relationship to Arterial Hypertension
AlKhuzaie, A. A.-M. M.-H. (2026) · International Journal of Biological and Biomedical Research · doi:10.54660/ijbbr.2026.2.3.20-25
食事誘導性肥満および糖尿病モデルラットにおける食後glucagon-like peptide-1分泌応答の変動とその役割
JUKKRAPONG, P. (2020) · Institutional Repositories DataBase (IRDB) · doi:10.14943/doctoral.k14209
Han, Y., Shon, J., & Park, Y. J. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2728313
“Postprandial GLP-1 level after oral glucose tolerance test were reduced in obesity, whereas the fasting GLP-1 level was not different between individuals with obesity and healthy individuals (Færch et al. 2015; Muscelli et al. 2008; Ranganath et al. 1996; Carr et al. 2010; Simon et al. 2014).”
Šantić, R., Kumrić, M., Kurir, T. T., Rušić, D., & Božić, J. (2026) · Molecules · doi:10.3390/molecules31193375
Sinha, L., Sonia, D., & Gupta, D. R. (2025) · NeuroQuantology · doi:10.48047/nq.2025.23.7.nq25042
Dede, S. (2025) · Yildiz Technical University - AVESIS
Dean, A. E. (2024) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Sharma, A., Lee-Ødegård, S., Holst, J. J., Hartmann, B., Kvist, A. A. S., Qvigstad, E., Sollid, S. T., Nermoen, I., & Birkeland, K. I. (2026) · Diabetologia · doi:10.1007/s00125-026-06898-w
Self-citation
Metadata
- Authors
- Færch, K., Torekov, S. S., Vistisen, D., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Sandbæk, A., Holst, J. J., & Jørgensen, M. E.
- Affiliations
- Steno Diabetes Center, Gentofte, Denmark
- University of Copenhagen (DK)
- Danish Diabetes Academy (DK)
- Section for General Practice, Department of Public Health, Aarhus, Denmark
- Corresponding author
- Færch, Kristine
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-02-12
- Volume
- 64
- Issue
- 7
- Pages
- 2513-2525
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2081594150
- Cited by
- 321
- References
- 54
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 30 · 2023: 28 · 2022: 27 · 2021: 34 · 2020: 28 · 2019: 41 · 2018: 26 · 2017: 20 · 2016: 22 · 2015: 11
- FWCI
- 22.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Novo Nordisk Foundation
- Danish Centre for Evaluation and Health Technology Assessment
- Diabetes Fund of the National Board of Health
- Danish Medical Research Council
- Aarhus University Research Foundation
- European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801)
- National Health Services in the counties of Copenhagen, Aarhus, Ringkøbing, Ribe, and Southern Jutland in Denmark
- Danish Council for Strategic Research
- Danish Research Foundation for General Practice
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- glucagon-like peptide-1, glucose-stimulated insulin secretion, prediabetes, type 2 diabetes, obesity, sex differences, oral glucose tolerance test, insulin sensitivity, beta-cell function
- MeSH terms
- Age Factors, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin, Male, Middle Aged, Obesity, Prediabetic State, Sex Characteristics, Body Mass Index, Glucagon-Like Peptide 1, Waist Circumference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.